TuHURA Biosciences (HURA) Long-Term Deferred Tax (2020)

TuHURA Biosciences' (HURA) quarterly Long-Term Deferred Tax came in at $85000.0 in Q2 2020.

TuHURA Biosciences (HURA) Long-Term Deferred Tax (2020) Analysis & Trends

TuHURA Biosciences' Long-Term Deferred Tax history runs 1 years deep, the most recent figure standing at $85000.0 for Q2 2020.

On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $85000.0 in Q2 2020; TTM through Jun 2020 was $85000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $85000.0, changed N/A from the prior year.
Long-Term Deferred Tax held at $85000.0 in Q2 2020 per HURA's latest filing.
Across five years, Long-Term Deferred Tax topped out at $85000.0 in Q2 2020 and bottomed at $85000.0 in Q2 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-
10	TuHURA Biosciences	132.62 Mn	132.62 Mn	-

Historic Data

Download Data

Date	Value
Jun 30, 2020	85,000.00